Weiyao Kong

机构：Shenzhen Bay Laboratory · ORCID：0000-0001-6444-6181

发表论文 22 篇 · 总被引 333 次 · h-index 10

代表论文

• USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells (2021 · Journal of Experimental & Clinical Cancer Research · 被引 61)
• HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma (2023 · Advanced Science · 被引 44)
• Selective degradation of AR-V7 to overcome castration resistance of prostate cancer (2021 · Cell Death and Disease · 被引 39)
• Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead‐Assisted Flow Cytometry Detection of Tumor‐Derived Extracellular Vesicles (2018 · Small Methods · 被引 37)
• SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16 (2022 · Acta Pharmacologica Sinica · 被引 26)
• Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients (2017 · The Breast · 被引 25)